The utility of the cystatin C test in diagnosing kidney disease
12. May 2021 |
3 min read
Webinar about cystatin C as an alternative to creatinine
In this exciting webinar a multidisciplinary panel of experts examine the clinical utility of the cystatin C test in diagnosing kidney disease. The aim of this discussion was to educate healthcare practitioners on the cystatin C testing option and help them effectively communicate the benefits of the test to their patients.
Content of the webinar:
Importance of Estimated GFR - Josef Coresh, MD, PhD Johns Hopkins University
The Epidemiological Argument for Cystatin C and Impact of GFR Staging on Medication Eligibility and Dosing - Michael Shlipak, MD, MPH San Francisco VA Health Care System and University of California, San Francisco
Clinical Case Examples - Michelle Estrella, MD, MHS San Francisco VA Health Care System and University of California, San Francisco
Barriers to widespread use of cystatin C and how to overcome them - Amy Karger, MD, PhD University of Minnesota
The webinar is sponsored by Gentian Diagnostics.
The Gentian Cystatin C Immunoassay
The Gentian Cystatin C Immunoassay is an open channel turbidimetric test for quantitative determination of cystatin C in human serum and plasma.
FDA510(k) cleared and CE-marked
Developed and manufactured by Gentian
Manufactured according to ISO 13485:2016
IVDR registration in progress
For more information or ordering cystatin C, please fill out the form below: